College of Pharmacy

7 Greenhouse Road Kingston, RI 02881

pharmcol@etal.uri.edu – Office: 401.874.2761 Fax: 401.874.2181

URI
Think Big, We Do.
Rhode Island Seal

Office of Continuing Professional Development

32nd Annual Seminar by the Sea

Northeast Regional
Continuing Education Conference for Pharmacists

Targeted Practice: Tailored Approaches,
Specialty Drugs, and the
Expanding Role of Pharmacy

 March 15 – March 17, 2017

Gurney’s Newport Resort and Marina (Formerly the Hyatt Regency Newport Hotel), 1 Goat Island, Newport RI 02840

Program announcement for Seminar by the Sea registrants! Wednesday Pre-Conference session program time change:

The Antimicrobial Stewardship pre conference program has been moved to the afternoon. Registration will open at 11:30. Lunch will be served at this time. The program will run from 12:30 pm to 4:30 pm. There is no change to the Preceptor Workshop on Wednesday or the Thursday and Friday program times.

Plenary Sessions: Thursday & Friday, March 16 & 17, 2017

2-Day Agenda

 

Thursday, March 16, 2017

 

 7:00 AM              Registration, Breakfast and Exhibitors, Grand Ballroom Foyer and Brenton Hall

8:00 AM              Welcome and Program Overview, Grand Ballroom

                                Mary-Jane Kanaczet, Director, Office of Continuing Professional Development

                               Paul Larrat, Dean, URI College of Pharmacy

 8:15 AM              Keynote Presentation                    

 9:15 AM              The Specialty Pharmacy Pipeline

                                Anita Dopkosky, RPh, MS, Director, Specialty Pharmacy Development, Walgreen Co

10:15 AM             Break, Brenton Hall with Exhibitors

10:45 AM             Make a Difference: You Can Help Patients Take cHArgE

                                Bethany Spadaro, PharmD, Rhode Island Primary Care Physician Corporation

12:00 PM             Luncheon and Exhibitors, Grandball Room and Brenton Hall              

 1:00 PM              Biosimilars: A Scientific, Clinical, and Regulatory Overview for Pharmacists

                                Rick Miller, Senior Director, Specialty Clinical Services, Walgreen Co.

2:00 PM              Advanced Patient Counseling: Motivational Interviewing

                                Erika Michalski, Ed.D.

 3:00 PM              Break, Brenton Hall with Exhibitors           

 3:30 PM              Treatment Updates for COPD

                                Christine Eisenhower, PharmD, BCPS

 4:30 PM              Pharmacy Law: There Seems to be a Mistake with My Prescription

                                Donna M. Horn, RPh, DPh (Hon.), Director Patient Safety – Community Pharmacy,
Institute for Safe Medication Practices (ISMP) and Adjunct Instructor,
Massachusetts College of Pharmacy and Health Sciences, School of Pharmacy

 5:30 PM              Wrap Up and Evaluations

                                Networking Reception with Sponsors, Brenton Hall



Friday, March 17, 2017

 

 7:00 AM              Registration, Breakfast and Exhibits, Grand Ballroom Foyer and Brenton Hall

 8:00 AM              Welcome, Program Overview, and Campbell Award Presentation, Grand Ballroom

                                 Mary-Jane Kanaczet, Director, Office of Continuing Professional Development

                                 Paul Larrat, Dean, URI College of Pharmacy

                                 Norman Campbell, Professor Emeritus and Ambassador, URI College of Pharmacy                           

8:15 AM               Keynote Presentation

Nicole Alexander-Scott, MD, MPH Director of the Rhode Island Department of Health

9:30 AM             The Pharmacist’s Role in Nutritional Counseling

10:30 AM             Break, Brenton Hall with Exhibitors

11:00 AM             GI Updates: Dietary Supplements for Weight Loss and Proton Pump Inhibitors

                                Anne Hume, PharmD, BCPS, Clinical Professor, URI College of Pharmacy

12:00 PM            Luncheon and Exhibitors, Grandball Room and Brenton Hall

1:00 PM               “To Poop or Not to Poop:” Treatment Updates for Opioid Constipation and IBS

                                Jayne Pawasauskas, PharmD, BCPS, Clinical Professor, URI College of Pharmacy,

                                Margaret Charpentier, PharmD, Clinical Associate Professor, URI College of Pharmacy,

 2:00 PM              Compassion Stress and Fatigue for Pharmacists:  What’s In Your Toolbox for Self-Care?

                                Donna M. White RN, PhD, CS, CADAC, Addiction Specialist, Lemuel Shattuck Hospital

 3:15 PM              Break

3:30 PM             Innovation and Excitement in Oncology:
Checkpoint Inhibitors and Personalized Vaccines

                               Annie De Groot, MD, CEO/CSO EpiVax, Inc. and Immune Engineer, Research Professor and Director, Institute for Immunology and Informatics,  The University of Rhode Island

4:30 PM               Pharmacy Legislative, Regulatory and Case Law Update

Martha M. Rumore, Pharm.D., M.S., J.D., L.L.M., FAPhA Associate Professor,   Touro College of Pharmacy, Adjunct Professor, Touro College Jacob D. Fuchsberg Law Center, Of Counsel , Sorell, Lenna, and Schmidt , LLP

5:30 PM               Wrap Up and Evaluations

                                Adjournment

 


LEARNING OBJECTIVES

At the conclusion of the program, participants will be able to:

  • Describe the trends in specialty drug development;
  • List the most recent FDA specialty drug approvals;
  • Differentiate between the various FDA expedited approval pathways;
  • Outline the near-term pipeline products by pertinent disease state (phase 3 and NDA file);
  • Discuss the differences between biologic, biosimilar and small molecule medications;
  • Assess the potential regulatory and utilization challenges related to biosimilars;
  • List the currently available/FDA approved biosimilar products and the short term development pipeline;
  • Describe the economic impact of biosimilar products and the potential for increased patient access;
  • Describe the scope and pathophysiology of opioid-induced constipation (OIC);
  • Apply evidence-based practices in the approach to managing opioid-induced constipation with older therapies;
  • Apply evidence-based practices in the approach to appropriate use of targeted therapies (PAMORAs);
  • Identify three symptoms of Secondary Traumatic Stress Disorder (STSD);
  • Describe how Secondary Traumatic Stress Disorder (STSD) and the sequelae Compassion Fatigue, may pose a personal, professional, and occupational risk to staff who care for or treat others in their daily clinical practice or work;
  • List two Evidence Based Occupational Supports for Professionals experiencing CF/STSD and the scientific process of promoting wellness.
  • Review the evidence on the safety and efficacy of dietary supplements for weight loss;
  • Identify key counselling points for working with patients who are using these dietary supplements;
  • Discuss ongoing controversies with proton pump inhibitors
  • Describe how to analyze a medication error using specific set of steps and tools to help identify the contributing factors and root cause of the event.
  • Explain how to use information gathered during a root cause analysis (RCA) to minimize the re-occurrence of medication errors.
  • Prepare an action plan from the RCA that include risk reduction strategies, communication, implementation strategies and effective outcome measurements.
  • Discuss recent changes to laws and regulations impacting pharmacists on the state and federal level.
  • Review important pharmacy-related court decisions, lawsuits, and settlements over the past year.
  • Understand the continuum of pharmacist prescriptive authority via Collaborative Practice Agreement Laws and State Protocols.

TARGET AUDIENCE

Community, hospital, managed care, academic and consultant pharmacists and other interested health care professionals.

 

Accreditation

acpesmaller

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Participants will receive 15.0 live contact hours (1.5 ceus) including 2.0 contact hours of pharmacy law and 1.0 contact hour of immunization for the live two-day program. This is a knowledge-based learning activity.

 

Requirements for Credit

Participants must sign in each day. Participants will receive a participant code for each session and must complete program evaluations on the URI web site at www.uripharmacycpd.org. CE credit will be automatically uploaded to the CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours. Credit will not be awarded to participants who complete the program evaluation more than 60 days post-activity.  CE statements and transcripts are available through your CPE Monitor account.

 

Universal Activity Numbers

Thursday, March 16, 2017

General Session UAN 0060-0000-17-005-L04-P        6.5 Contact Hours                (0.65 ceus)

Pharmacy Law     UAN 0060-0000-17-007-L03-P        1.0 Contact Hour                 (0.1 ceus)

Friday, March 17, 2017

General Session UAN 0060-0000-17-008-L04-P        5.5 Contact Hours               (0.55 ceus)

Immunization        UAN 0060-0000-17-006-L01-P        1.0 Contact Hour                (0.1 ceus)

Pharmacy Law     UAN 0060-0000-17-009-L03-P        1.0 Contact Hour                 (0.1 ceus)

Copyright © 2017 University of Rhode Island.

The University of Rhode Island
Think Big, We Do.
A-ZDirectoryContact UsJump to top